Inflammation and tumor progression: signaling pathways and targeted intervention

H Zhao, L Wu, G Yan, Y Chen, M Zhou… - Signal transduction and …, 2021 - nature.com
Cancer development and its response to therapy are regulated by inflammation, which
either promotes or suppresses tumor progression, potentially displaying opposing effects on …

The hypothalamic–pituitary–adrenal axis and immune-mediated inflammation

GP Chrousos - New England Journal of Medicine, 1995 - Mass Medical Soc
Celsus described four of the five cardinal signs of inflammation 2000 years ago, and
Eustachio discovered the adrenal glands almost 500 years ago, but not until 1936 did Selye …

HMG-1 as a late mediator of endotoxin lethality in mice

H Wang, O Bloom, M Zhang, JM Vishnubhakat… - Science, 1999 - science.org
Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages to release
large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate …

The pathogenesis of sepsis

RC Bone - Annals of internal medicine, 1991 - acpjournals.org
▪ Sepsis and its sequelae (sepsis syndrome and septic shock) are increasingly common and
are still potentially lethal diagnoses. Many mediators of the pathogenesis of sepsis have …

Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view

W Schulte, J Bernhagen, R Bucala - Mediators of inflammation, 2013 - Wiley Online Library
Sepsis and septic shock are among the leading causes of death in intensive care units
worldwide. Numerous studies on their pathophysiology have revealed an imbalance in the …

Multiple organ failure pathophysiology and potential future therapy

EA Deitch - Annals of surgery, 1992 - journals.lww.com
Multiple organ failure (MOF) has reached epidemic proportions in most intensive care units
and is fast becoming the most common cause of death in the surgical intensive care unit …

The pathophysiologic roles of interleukin-6 in human disease

DA Papanicolaou, RL Wilder… - Annals of internal …, 1998 - acpjournals.org
Interleukin-6, an inflammatory cytokine, is characterized by pleiotropy and redundancy of
action. Apart from its hematologic, immune, and hepatic effects, it has many endocrine and …

Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

JE Parrillo, MM Parker, C Natanson… - Annals of internal …, 1990 - acpjournals.org
Septic shock is the commonest cause of death in intensive care units. Although sepsis
usually produces a low systemic vascular resistance and elevated cardiac output, strong …

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled …

CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk… - Jama, 1994 - jamanetwork.com
Objective.—To further define the safety and efficacy of recombinant human interleukin 1
receptor antagonist (rhIL-1ra) in the treatment of sepsis syndrome. Study Design …

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

P Damas, D Ledoux, M Nys, Y Vrindts… - Annals of …, 1992 - ncbi.nlm.nih.gov
Forty critically ill surgical patients with documented infections were studied during their stay
in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of …